An Open Label, Multicenter Study Evaluating the Imaging Characteristics of a Follow up 18F-AV-1451 Scan in Subjects That Participated in the Confirmatory Cohort of 18F-AV-1451-A05
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Flortaucipir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 14 Sep 2017 Status changed from recruiting to completed.
- 23 Jan 2017 Status changed from not yet recruiting to recruiting.
- 29 Jun 2016 New trial record